Co-Authors
This is a "connection" page, showing publications co-authored by Lang Ding and XIAOLI QI.
Connection Strength
0.170
-
Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024 Dec 16; 15(1):10683.
Score: 0.061
-
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity. Res Sq. 2024 Apr 08.
Score: 0.058
-
Discovery of a potent BTK and IKZF1/3 triple degrader through reversible covalent BTK PROTAC development. Curr Res Chem Biol. 2022; 2.
Score: 0.051